11 April 2017Americas
Novartis and Roxane enter settlement over cancer treatment
Novartis and Roxane Laboratories have entered into a settlement agreement following a patent dispute between the parties over a cancer treatment.
Novartis and Roxane Laboratories have entered into a settlement agreement following a patent dispute between the parties over a cancer treatment.
